Liquid Deprenyl Citrate
This article was originally published in The Tan Sheet
Executive Summary
Discovery Experimental & Development, doing business as Astak, receives FDA warning letter Aug. 16 for claims Liquid Deprenyl Citrate is an effective treatment for diseases including depression, senile dementia, Parkinson's disease, Alzheimer's disease, ALS (Lou Gehrig's disease), high blood pressure, stroke induced paralysis and mental dysfunction. The product is classified by the agency as an unapproved new drug. The Wesley Chapel, Fla.-based firm did not follow the proper procedure when exporting the product to the U.K., FDA adds